Elanco Animal Health Again Cuts Annual Guidance After Mixed Q2 Earnings


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


  • Elanco Animal Health Inc (NYSE:ELAN) has reported a Q2 adjusted EPS of $0.36, higher than the $0.28 reported a year ago, surpassing analysts' view of $0.25.
  • Revenue was $1.177 billion, a decrease of 8% Y/Y on a reported basis, or down 4%, excluding the unfavorable impact of foreign exchange rates, almost in line with the consensus of $1.18 billion.
  • Pet Health's revenue decreased by 11% (-7% CER) to $612 million, with a 1% increase in price partially offset by rebate and in-store marketing programs, primarily in the U.S. retail business.
  • Farm Animal revenue decreased 2% (+3% CER) as Rumensin sales were partially offset by pressured economics for swine and poultry producers in China and a decline for swine in Europe. 
  • Adjusted gross margin improved by 190 bps compared to 58.9%.
  • Guidance: Elanco expects FY22 revenue of $4.46 - $4.55 billion, down from previous guidance of $4.70 - $4.76 billion and the consensus of $4.69 billion.
  • It expects adjusted EPS of $1.06-$1.13, down from previous guidance of $1.15 - $1.21 (consensus of $1.14).
  • The company lowered adjusted EBITDA guidance to $1.06-$1.1 billion vs. the previous outlook of $1.12 - $1.16 billion.
  • For Q3, the company forecasts revenue of $1.01-$1.06 billion, below the consensus of $1.14 billion.
  • It expects adjusted EPS of $0.12 - $0.18 (consensus of $0.26) and adjusted EBITDA of $175 million - $215 million.
  • Price Action: ELAN shares are up 3.60% at $20.14 during the premarket session on the last check Monday.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsLarge CapNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefs